VISTERRA, INC.
Patent Applications and Registrations
Patent applications and USPTO patent grants for VISTERRA, INC..The latest application filed is for "antibody molecule-drug conjugates and uses thereof".
Company Profile
25.36.44
Trademarks
- VISTERRA, INC. - Waltham MA US
- VISTERRA, INC. - Cambridge MA US
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Antibody Molecule-drug Conjugates And Uses Thereof App 20220267418 - Plante; Obadiah Joseph ; et al. | 2022-08-25 |
| Antibody Molecules To A Proliferation-inducing Ligand (april) App 20220235124 - Myette; James R. ; et al. | 2022-07-28 |
| Interleukin-2 Agents And Uses Thereof App 20220226442 - Carlson; Scott Moore ; et al. | 2022-07-21 |
| Ha Binding Agents App 20220204592 - Shriver; Zachary ; et al. | 2022-06-30 |
| Antibody Molecules To Dengue Virus And Uses Thereof App 20220177553 - Robinson; Luke ; et al. | 2022-06-09 |
| Methods Of Using Interleukin-2 Agents App 20220177535 - Carlson; Scott Moore ; et al. | 2022-06-09 |
| Antibody Molecules to C5AR1 and Uses Thereof App 20220089764 - Viswanathan; Karthik ; et al. | 2022-03-24 |
| Methods For Identifying Epitopes And Paratopes App 20220059184 - Wollacott; Andrew M. ; et al. | 2022-02-24 |
| Compositions and methods for treating and preventing influenza Grant 11,230,593 - Narayan , et al. January 25, 2 | 2022-01-25 |
| Antibody molecule-drug conjugates and uses thereof Grant 11,168,131 - Plante , et al. November 9, 2 | 2021-11-09 |
| Antibody Molecules To April And Uses Thereof App 20210340266 - Myette; James R. ; et al. | 2021-11-04 |
| Antibody Molecule-drug Conjugates And Uses Thereof App 20210316004 - Viswanathan; Karthik ; et al. | 2021-10-14 |
| Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule Grant 11,136,385 - Myette , et al. October 5, 2 | 2021-10-05 |
| Antibody Molecule-drug Conjugates And Uses Thereof App 20210283220 - Shriver; Zachary ; et al. | 2021-09-16 |
| Antibody molecules to dengue virus and uses thereof Grant 11,059,883 - Robinson , et al. July 13, 2 | 2021-07-13 |
| Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL) Grant 10,981,982 - Myette , et al. April 20, 2 | 2021-04-20 |
| Antibody molecules to a proliferation-inducing ligand (APRIL) Grant 10,968,270 - Myette , et al. April 6, 2 | 2021-04-06 |
| Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA Grant 10,954,296 - Myette , et al. March 23, 2 | 2021-03-23 |
| Formulations Of Antibody Molecules To Influenza Virus App 20210054053 - Sloan; Susan ; et al. | 2021-02-25 |
| Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA Grant 10,919,960 - Myette , et al. February 16, 2 | 2021-02-16 |
| Antibody Molecules To A Proliferation-inducing Ligand (april) App 20210032324 - Myette; James R. ; et al. | 2021-02-04 |
| Interleukin-2 Agents And Uses Thereof App 20210024601 - Carlson; Scott Moore ; et al. | 2021-01-28 |
| Humanized Antibody Molecules To Cd138 And Uses Thereof App 20200392241 - Chaganty; Bharat ; et al. | 2020-12-17 |
| Antibody Molecules To A Proliferation-inducing Ligand (april) App 20200331995 - Myette; James R. ; et al. | 2020-10-22 |
| HA binding agents Grant 10,800,835 - Shriver , et al. October 13, 2 | 2020-10-13 |
| Antibody Molecules To A Proliferation-inducing Ligand (april) App 20200317770 - Myette; James R. ; et al. | 2020-10-08 |
| Compositions And Methods For Treating And Preventing Influenza App 20200308257 - Narayan; Kristin ; et al. | 2020-10-01 |
| Antibody Molecules To A Proliferation-inducing Ligand (april) App 20200299376 - Myette; James R. ; et al. | 2020-09-24 |
| Engineered Polypeptides And Uses Thereof App 20200277358 - Viswanathan; Karthik ; et al. | 2020-09-03 |
| Formulations Of Antibody Molecules To Dengue Virus App 20200237913 - Hay; Catherine ; et al. | 2020-07-30 |
| Compositions And Methods For Treating And Preventing Influenza App 20200231657 - Wollacott; Andrew M. ; et al. | 2020-07-23 |
| Formulations Of Antibody Molecules To Influenza Virus App 20200181243 - Sloan; Susan ; et al. | 2020-06-11 |
| Compositions and methods for treating and preventing influenza Grant 10,513,553 - Wollacott , et al. Dec | 2019-12-24 |
| Antibody Molecules To A Proliferation-inducing Ligand (april) App 20190330326 - Myette; James R. ; et al. | 2019-10-31 |
| Antibody molecules to a proliferation-inducing ligand (APRIL) Grant 10,385,123 - Myette , et al. A | 2019-08-20 |
| Antibody Molecules To Dengue Virus And Uses Thereof App 20190153074 - Robinson; Luke ; et al. | 2019-05-23 |
| Antibody Molecules To Cd138 And Uses Thereof App 20190100588 - Chaganty; Bharat ; et al. | 2019-04-04 |
| Antibody Molecules To April And Uses Thereof App 20190092851 - Myette; James R. ; et al. | 2019-03-28 |
| Novel Ha Binding Agents App 20190002536 - Shriver; Zachary ; et al. | 2019-01-03 |
| Antibody molecules to dengue virus and uses thereof Grant 10,155,806 - Robinson , et al. Dec | 2018-12-18 |
| Binding Polypeptides And Methods Of Making The Same App 20180201926 - Shriver; Zachary ; et al. | 2018-07-19 |
| HA binding agents Grant 9,969,794 - Shriver , et al. May 15, 2 | 2018-05-15 |
| Engineered Polypeptides And Uses Thereof App 20180037634 - Viswanathan; Karthik ; et al. | 2018-02-08 |
| Antibody Molecules To Zika Virus And Uses Thereof App 20170298119 - Wollacott; Andrew M. ; et al. | 2017-10-19 |
| Formulations Of Antibody Molecules To Dengue Virus App 20170274076 - Hay; Catherine ; et al. | 2017-09-28 |
| Formulations Of Antibody Molecules To Influenza Virus App 20170240617 - Sloan; Susan ; et al. | 2017-08-24 |
| Antibody Molecules To April And Uses Thereof App 20170145086 - Myette; James R. ; et al. | 2017-05-25 |
| Compositions And Methods For Treating And Preventing Influenza App 20170137498 - Wollacott; Andrew M. ; et al. | 2017-05-18 |
| Antibody Molecule-drug Conjugates And Uses Thereof App 20170129942 - Plante; Obadiah Joseph ; et al. | 2017-05-11 |
| Synthetic Oligosaccharides For Moraxella Vaccine App 20160375120 - Campbell; A. Stewart ; et al. | 2016-12-29 |
| Synthetic oligosaccharides for moraxella vaccine Grant 9,447,133 - Campbell , et al. September 20, 2 | 2016-09-20 |
| Antibody Molecules To Dengue Virus And Uses Thereof App 20160251413 - Robinson; Luke ; et al. | 2016-09-01 |
| Antibody molecules to dengue virus and uses thereof Grant 9,365,639 - Robinson , et al. June 14, 2 | 2016-06-14 |
| Antibody Molecules To Dengue Virus And Uses Thereof App 20160046697 - Robinson; Luke ; et al. | 2016-02-18 |
| Antibody molecules to dengue virus and uses thereof Grant 9,212,217 - Robinson , et al. December 15, 2 | 2015-12-15 |
| Antibody Molecules To Dengue Virus And Uses Thereof App 20150225474 - Robinson; Luke ; et al. | 2015-08-13 |
| HA binding agents Grant 9,096,657 - Shriver , et al. August 4, 2 | 2015-08-04 |
| Novel Ha Binding Agents App 20150037352 - Shriver; Zachary ; et al. | 2015-02-05 |
| HA binding agents Grant 8,877,200 - Shriver , et al. November 4, 2 | 2014-11-04 |
| Novel Ha Binding Agents App 20140148581 - Shriver; Zachary ; et al. | 2014-05-29 |
| Novel Ha Binding Agents App 20130302349 - Shriver; Zachary ; et al. | 2013-11-14 |
Company Registrations
| NCAGE Code | 6G8T0 | VISTERRA, INC. |
| NCAGE Code | 6C543 | VISTERRA, INC.!DBA PARASOL THERAPEUTICS |
| CAGE Code | 6G8T0 | VISTERRA, INC. |
| CAGE Code | 6C543 | VISTERRA, INC. PARASOL THERAPEUTICS |
| S.A.M. Registration | 6G8T0 [69553049] | VISTERRA, INC. |
| SEC | 0001426375 | Visterra, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 